Search results
50 Results for 'Pamela Silver'
- Technologies (1)
- Team (0)
- News (38)
- Events (4)
- Multimedia (7)
- Publications (0)
- Jobs (0)
Technologies 1
A broad strategy to reduce the toxicity of protein drugsNews 38
Events 4
-
Jun 7, 2019, 8:00am - 6:00pm
Symposium
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
Wyss Core Faculty member Pam Silver will be the keynote speaker at the Mid-Atlantic Synthetic Biology Symposium at the University of Virginia. Her talk is entitled, “Designing Biology for Health and Sustainability.” This event is a one-day meeting of the mid-Atlantic Synthetic Biology community. -
Nov 27, 2018, 1:00pm - 2:00pm
Lecture
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
On Tuesday, November 27, join Brigham and Women’s Hospital for the weekly Clinical Pathology Conference lecture series featuring Wyss Core Faculty member Pamela Silver. Pamela Silver is leveraging synthetic biology to build cells that act as sensors, memory devices, and drug delivery agents. Among her recent innovations are bacteria that sense and respond to gut... Free and open to public -
May 5 → 6, 2018
Workshop
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
This workshop will explore the latest trends and advances in the field, including recent foundational accomplishments and applications in addressing challenges to human health and beyond. This one-and-a-half day meeting brings together world’s leading researchers in synthetic biology, mammalian and cellular biology, and bioengineering from academic as well as industry partners. Our scientific program will...
Multimedia 7
-
Video/AnimationDistributed Cell Division CounterGenetically engineered E. coli containing a fluorescing red protein enabled a Wyss Institute and Harvard Medical School team to analyze the population fluctuations of gut microbes by comparing proportion of “marked” to “unmarked” cells. Credit: Wyss Institute at Harvard University -
Video/AnimationGastrointestinal Re-ProgrammingIn this animation, see an example of how genetically engineered microbes being developed by researchers at the Wyss Institute could detect and treat a wide range of gastrointestinal illnesses and conditions. Credit: Wyss Institute at Harvard University -
Video/AnimationCircadian TransplantThe first successful transplant of a circadian rhythm into a naturally non-circadian species could lead to precisely timed release of drugs and other innovative therapeutic applications. In this video, gut bacteria (E. coli) exhibit a circadian rhythm after circadian oscillators were transferred from cyanobacteria. The ‘mother cell’ at the top blinks on and off with... -
Audio/PodcastDisruptive: Synthetic BiologyWhat sorts of breakthroughs are possible by modifying an organism’s genome – something researchers are now able to do ever more cheaply and efficiently? Researchers around the world are already able to program microbes to treat waste water, generate electricity, manufacture jet fuel, create hemoglobin, and fabricate new drugs. What sounds like science fiction to... -
Video/AnimationDesigning Fusion-Protein TherapiesIn this video, watch the new computational model in action as it simulates the behavior of a fusion-protein drug molecule after the targeting protein has attached to a cell. Developed by Wyss researchers, this model helps design more effective biologic drugs while eliminating drug candidates that are prone to causing side effects. Credit: Harvard’s Wyss... -
Video/AnimationMagnetic YeastIn this video, Wyss Core Faculty member Pamela Silver describes how her team at the Wyss Institute and Harvard Medical School induced magnetic sensitivity in a non-magnetic organism. This technology could potentially be used to magnetize a variety of different cell types in medical, industrial and research applications. Credit: Wyss Institute at Harvard University